Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.

Morris EE, Amria MY, Kistner-Griffin E, Svenson JL, Kamen DL, Gilkeson GS, Nowling TK.

Arthritis Res Ther. 2010;12(6):R212. doi: 10.1186/ar3189. Epub 2010 Nov 18.

2.

Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.

Nowling TK, Fulton JD, Chike-Harris K, Gilkeson GS.

Mol Immunol. 2008 Jan;45(1):1-12. Epub 2007 Jul 2.

3.

Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.

Schotte H, Gaubitz M, Willeke P, Tidow N, Assmann G, Domschke W, Schlüter B.

Rheumatology (Oxford). 2004 Nov;43(11):1357-63. Epub 2004 Aug 10.

PMID:
15304673
4.

A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N.

PLoS Genet. 2011 Jun;7(6):e1002128. doi: 10.1371/journal.pgen.1002128. Epub 2011 Jun 30.

5.

Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.

Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK.

PLoS One. 2013 Sep 10;8(9):e75175. doi: 10.1371/journal.pone.0075175. eCollection 2013.

6.

The Fli-1 transcription factor regulates the expression of CCL5/RANTES.

Lennard Richard ML, Sato S, Suzuki E, Williams S, Nowling TK, Zhang XK.

J Immunol. 2014 Sep 15;193(6):2661-8. doi: 10.4049/jimmunol.1302779. Epub 2014 Aug 6.

7.

Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.

Lee YH, Kim YR, Ji JD, Sohn J, Song GG.

J Rheumatol. 2001 Sep;28(9):2008-11.

PMID:
11550967
8.

TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus.

Santos MJ, Carmona-Fernandes D, Caetano-Lopes J, Perpétuo IP, Vidal B, Capela S, Canas da Silva J, Fonseca JE.

Rheumatol Int. 2012 Aug;32(8):2239-44. doi: 10.1007/s00296-011-1950-7. Epub 2011 May 5.

PMID:
21544635
9.

Association between TNF promoter -308 G>A and LTA 252 A>G polymorphisms and systemic lupus erythematosus.

Ahmed HH, Taha FM, Darweesh Hel-S, Morsi HM.

Mol Biol Rep. 2014;41(4):2029-36. doi: 10.1007/s11033-014-3051-7. Epub 2014 Jan 14.

PMID:
24420856
10.

Relationship between MCP-1 promoter -2518 A/G gene polymorphism (rs1024611) and systemic lupus erythematosus/lupus nephritis.

Zhou TB, Jiang ZP, Liang MJ, Huang YJ.

J Recept Signal Transduct Res. 2015 Feb;35(1):85-93. doi: 10.3109/10799893.2014.931433. Epub 2014 Jun 26.

PMID:
24968246
11.

Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes.

Suresh S, Demirci FY, Jacobs E, Kao AH, Rhew EY, Sanghera DK, Selzer F, Sutton-Tyrrell K, McPherson D, Bontempo FA, Kammerer CM, Ramsey-Goldman R, Manzi S, Kamboh MI.

J Rheumatol. 2009 Feb;36(2):315-22. doi: 10.3899/jrheum.080482.

12.

Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.

Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K.

Lupus. 2013 Jun;22(7):721-6. doi: 10.1177/0961203313486192. Epub 2013 May 2.

PMID:
23640982
13.

Genetic analysis of interleukin-10 promoter region in patients with systemic lupus erythematosus in Taiwan.

Ou TT, Tsai WC, Chen CJ, Chang JG, Yen JH, Wang WS, Lin CH, Tsai JJ, Liu HW.

Kaohsiung J Med Sci. 1998 Oct;14(10):599-606.

PMID:
9819501
14.

Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus.

Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL.

Genes Immun. 2004 Sep;5(6):484-92.

PMID:
15295621
15.

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.

Arthritis Rheum. 2006 Sep;54(9):2951-62.

16.

The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function.

Guillon N, Tirode F, Boeva V, Zynovyev A, Barillot E, Delattre O.

PLoS One. 2009;4(3):e4932. doi: 10.1371/journal.pone.0004932. Epub 2009 Mar 23.

17.

4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis.

Muñoz SA, Aranda F, Allievi A, Orden AO, Perés Wingeyer S, Trobo R, Alvarez A, Eimon A, Barreira JC, Schneeberger E, Dal Pra F, Sarano J, Hofman J, Chamorro J, de Larrañaga G.

Clin Exp Med. 2014 Feb;14(1):83-9. doi: 10.1007/s10238-012-0221-6. Epub 2012 Nov 11.

PMID:
23143392
18.

A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis.

Kim K, Sung YK, Kang CP, Choi CB, Kang C, Bae SC.

Genes Immun. 2009 Jul;10(5):482-6. doi: 10.1038/gene.2009.5. Epub 2009 Mar 5.

PMID:
19262578
19.

CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Zhai JX, Zou LW, Zhang ZX, Fan WJ, Wang HY, Liu T, Ren Z, Dai RX, Ye D.

Mol Biol Rep. 2013 Sep;40(9):5213-23. doi: 10.1007/s11033-012-2125-7. Epub 2013 Aug 7.

PMID:
23922195
20.

Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.

Niu Z, Zhang P, Tong Y.

Int J Rheum Dis. 2015 Jan;18(1):17-28. doi: 10.1111/1756-185X.12528. Epub 2014 Dec 26. Review.

PMID:
25546242

Supplemental Content

Support Center